Canopy Growth’s (NASDAQ:CGC) international subsidiary Canopy Growth Polska is withdrawing its medical marijuana strain Penelope from the market, writes Born2Invest. One of the leading suppliers of medical marijuana in Poland decided to withdraw the popular strain that contains 8% THC and 7% CBD due to the aging of the strain, which has made its quality unstable. “The decision to discontinue Penelope was very difficult for us, as it is a strain that enjoyed huge interest. However, our commitment to providing only the highest quality products forced us to take this step,” said a representative o…
